Wordt geladen...
Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
Etelcalcetide is a new calcimimetic indicated for the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients. Etelcalcetide efficacy in SHPT has been ascertained only in randomized controlled trials. This multicenter study was carried out in “real world” setting that is different fro...
Bewaard in:
| Gepubliceerd in: | J Clin Med |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6678718/ https://ncbi.nlm.nih.gov/pubmed/31330805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8071066 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|